Capricor Therapeutics Inc (CAPR)

12:29 PM

What is the latest on Capricor Therapeutics' Deramiocel and its FDA journey - Kavout

12:29 PM

May 20, 2026

Should you sell your Capricor Therapeutics stock? - Cantech Letter

May 20, 2026

May 20, 2026

Capricor’s Earnings Call: Deramiocel Drives High-Stakes Pivot - TipRanks

May 20, 2026

May 19, 2026

CAPR stock sinks after-hours: Capricor launches legal fight over DMD therapy rollout ahead of FDA review - MSN

May 19, 2026

May 19, 2026

CAPRICOR (CAPR) CFO exercises stock options to acquire 3,000 shares - Stock Titan

May 19, 2026

May 19, 2026

10,000-share sale amendment for CAPR (NASDAQ: CAPR) - Stock Titan

May 19, 2026

May 19, 2026

CAPR (NASDAQ: CAPR) lists recent purchases and awards in Form 144 - Stock Titan

May 19, 2026

May 18, 2026

(CAPR) and the Role of Price-Sensitive Allocations - Stock Traders Daily

May 18, 2026

May 17, 2026

Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection - MSN

May 17, 2026

May 17, 2026

Top 10 healthcare stocks by forward P/E: From Capricor's 418x to Alignment Healthcare's 48x - MSN

May 17, 2026

May 15, 2026

Roth MKM Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $38 - Moomoo

May 15, 2026

May 15, 2026

CAPR Stock Price, Quote & Chart | CAPRICOR THERAPEUTICS INC (NASDAQ:CAPR) - ChartMill

May 15, 2026

May 15, 2026

Capricor Faces Revenue Risk as Dependence on Nippon Shinyaku Puts Deramiocel Commercialization in Jeopardy - TipRanks

May 15, 2026

May 14, 2026

Capricor Therapeutics, Inc. Q1 2026 earnings preview - MSN

May 14, 2026

May 14, 2026

Capricor (CAPR) Q1 2026 Earnings Transcript - AOL.com

May 14, 2026

May 14, 2026

Capricor Therapeutics (CAPR) director boosts stake via 3,937-share option exercise - Stock Titan

May 14, 2026

May 14, 2026

CAPR: Capricor Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

May 14, 2026

May 13, 2026

CAPRICOR THERAPEUTICS, INC. 1Q 2026: Revenue $9.4M, EPS ($0.59) — 10-Q Summary - TradingView

May 13, 2026

May 13, 2026

[10-Q] CAPRICOR THERAPEUTICS, INC. Quarterly Earnings Report - Stock Titan

May 13, 2026

May 13, 2026

CAPR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

May 13, 2026

May 13, 2026

Capricor drops following filing of lawsuit against Nippon Shinyaku - MSN

May 13, 2026

May 13, 2026

Capricor stock price target held at $63 by B.Riley on FDA progress - Investing.com UK

May 13, 2026

May 13, 2026

H.C. Wainwright Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $60 - Moomoo

May 13, 2026

May 13, 2026

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2026 Earnings Call Transcript - Insider Monkey

May 13, 2026

May 13, 2026

Capricor Lawsuit Puts Duchenne Therapy Launch Plans And Valuation In Focus - Yahoo Finance

May 13, 2026

May 13, 2026

Capricor Therapeutics Inc (CAPR) Q1 2026 Earnings Call Highlights: Strong Cash Position Amid Legal Challenges - GuruFocus

May 13, 2026

May 13, 2026

Capricor Therapeutics (CAPR) Provides Update on FDA Review and C - GuruFocus

May 13, 2026

May 12, 2026

Capricor Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 12, 2026

May 12, 2026

Capricor Therapeutics Q1 Earnings Call Highlights - sharewise.com

May 12, 2026

May 12, 2026

Is Capricor Therapeutics (CAPR) Overvalued After Q1 2026 Update? - GuruFocus

May 12, 2026

May 12, 2026

Earnings call transcript: Capricor Therapeutics misses Q1 2026 EPS expectations - Investing.com India

May 12, 2026

May 12, 2026

Capricor Therapeutics: Runway Through 4Q27 >CAPR - Moomoo

May 12, 2026